Concepedia

Avivit Cahn

AC

Statistics

Publications

60

Citations

10.4K

H-Index

33

Active since

2009

Affiliations

Hebrew University of Jerusalem(Current)

Hadassah Medical Center

Brigham and Women's Hospital

Thrombolysis in Myocardial Infarction Study Group

The University of Texas Southwestern Medical Center

Avivit Cahn is an author at Hebrew University of Jerusalem specializing in medicine, diabetes, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2009–2023

60

Publications

60

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6K citations · Full text

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn et al. · The Lancet Diabetes & Endocrinology · 2019 · 656 citations · Full text

, , +10

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

Eri Kato, Michael G. Silverman, Ofri Mosenzon et al. · Circulation · 2019 · 550 citations

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction

Remo H.M. Furtado, Marc P. Bonaca, Itamar Raz et al. · Circulation · 2019 · 327 citations

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Ofri Mosenzon, Gil Leibowitz, Deepak L. Bhatt et al. · Diabetes Care · 2016 · 267 citations

1–5 of 60